Archives20242023202220212020201920182017201620152014201320122011 November 28, 2017Update on Lupuzor™ Pivotal Phase III Study Read More November 28, 2017ImmuPharma PLC (“ImmuPharma” or the “Company”) Holding(s) in Company Read More November 06, 2017Successful Completion of Lanstead Sharing Agreement Read More September 27, 2017Interim Results Announcement for the six months ended 30 June 2017 Read More September 27, 2017ImmuPharma initiates preparation of Lupuzor’s™ regulatory submissions Read More September 21, 2017Update on Lupuzor™ Pivotal Phase III Study Read More July 03, 20172017 Annual General Meeting – All Resolutions Passed Read More June 30, 2017Annual General Meeting and Investor Presentation Read More June 07, 2017Notice of Annual General Meeting on 30 June 2017 at 10.30am Read More June 06, 2017Final Results Announcement for the twelve months ended 31 December 2016 Read More May 24, 2017Notification of full year results – 1st June 2017 Read More May 18, 2017Update on Lupuzor™ Pivotal Phase III Study Read More 12
